MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-20-0005024
Indur Life Sciences Private Limited
Indur Life Sciences Private Limited - chemicals and materials in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.35 Lakh
▼ 99% YoY
Net loss · FY 2024
₹3.06 Lakh
Net margin -226.5%
EBITDA · FY 2024
-₹1.34 Lakh
EBITDA margin -99.2%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹6 Cr
Issued & subscribed
Open charges
₹11 Cr
Satisfied ₹4.8 Cr
Company age
15 yrs
Est. 2011
Directors on board
5
As per MCA filings
About Indur Life Sciences Private Limited
Data last updated:
Indur Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 18 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U45208TG2011PTC073379. Its GSTIN is 36AACCI5625C1ZW (Telangana). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹6 Cr. It was formerly known as Indur Pharma City Private Limited. It is led by directors including Muralidhar Rambathri (Managing Director) and Raghotham Reddy Enakonda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 202 Prestige Park Gundla Pochampally Village Medchal, Hyderabad, Telangana, India – 500014.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.35 Lakh, a decline of 99% compared to the previous year. For the same year it recorded a net loss of ₹3.06 Lakh (net margin -226.5%) and EBITDA of -₹1.34 Lakh (EBITDA margin -99.2%). Revenue has declined at a compounded annual rate (CAGR) of 89% over three years and 54% over five years.
As per MCA filings, the company has open charges of ₹11 Cr and satisfied charges of ₹4.8 Cr on record.
Indur Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0005024). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Indur Life Sciences Private Limited
CIN U45208TG2011PTC073379
Registration Number 073379
Incorporation Date 18 March 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0005024
CIN History of Indur Life Sciences Private Limited
Indur Life Sciences has one previous CIN (Corporate Identification Number): U45208AP2011PTC073379. The current CIN is U45208TG2011PTC073379, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U45208TG2011PTC073379 | Current |
| U45208AP2011PTC073379 | Previous |
Key People
Muralidhar Rambathri Managing Director Raghotham Reddy Enakonda Director Hema Rambathri Director Recognitions & Rankings of Indur Life Sciences
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 202 Prestige Park Gundla Pochampally Village Medchal, Hyderabad, Telangana, India – 500014
- IndustryChemicals and Materials, Chemical Distribution & Retail
Comprehensive company report
Indur Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Indur Life Sciences Private Limited
The main business activity of Indur Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Indur Life Sciences Private Limited FY 2025 filings available
Indur Life Sciences Private Limited reported revenue of ₹1.35 Lakh (down 99% YoY) for FY 2024.
Revenue · FY 2024
₹1.35 Lakh ▼ 99%
Net loss · FY 2024
₹3.06 Lakh margin -226.5%
EBITDA · FY 2024
-₹1.34 Lakh margin -99.2%
Compounded Annual Growth Rate (CAGR) of Indur Life Sciences Private Limited
Revenue CAGR growth
1 year
▼ 99%
3 years · compounded
▼ 89%
5 years · compounded
▼ 54%
EBITDA CAGR growth
1 year
▼ 105%
3 years · compounded
▼ 27%
5 years · compounded
▼ 30%
Revenue has declined at a compounded annual rate (CAGR) of 54% over five years, including a 99% fall in the latest year. EBITDA fell 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Indur Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.34 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.06 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Indur Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -99.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -226.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Indur Life Sciences are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Indur Life Sciences Private Limited
Indur Life Sciences has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Muralidhar Rambathri Also directs: Maa Laboratories Private Limited | Managing Director | 18 Mar 2011 | 15 Years 7 Months | Current |
| Raghotham Reddy Enakonda | Director | 08 Oct 2020 | 6 Years 0 Months | Current |
| Hema Rambathri Also directs: Maa Laboratories Private Limited | Director | 25 Feb 2012 | 14 Years 7 Months | Current |
| Gouthami Gankidi Also directs: GVR Infraconstructions India Private Limited | Additional Director | 17 Mar 2023 | 3 Years 7 Months | Current |
| Ajay Kumar Reddy Karnavathula | Additional Director | 23 Mar 2023 | 3 Years 6 Months | Current |
Peer Comparison of Indur Life Sciences Private Limited
Indur Life Sciences Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunlarge Technology Park Private Limited | ₹1.4 Lakh (FY 2025) | •••• | •••• | -86.0% | •••• | Bangalore, Karnataka, India |
| Yashoda Healthcare Private Limited | ₹1.39 Lakh (FY 2024) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Primecare Global Private Limited | ₹1.37 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Bangalore, Karnataka, India |
| Inovio Clinical Trials Private Limited | ₹1.36 Lakh (FY 2021) | •••• | •••• | 36.0% | •••• | Kashipur, Uttarakhand, India |
| Vrmdb Services Private Limited | ₹1.36 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Indur Life Sciences Private Limited this company | ₹1.35 Lakh (FY 2024) | •••• | •••• | -99.0% | •••• | Hyderabad, Telangana, India |
| Next Wave Global Technologies Private Limited | ₹1.35 Lakh (FY 2024) | •••• | •••• | -46.0% | •••• | Hyderabad, Telangana, India |
| Curomates Enterprise Private Limited | ₹1.33 Lakh (FY 2025) | •••• | •••• | 239.0% | •••• | Mumbai, Maharashtra, India |
| Mydream Mystory Foundation | ₹1.33 Lakh (FY 2023) | •••• | •••• | •••• | Delhi, India | |
| Live to Give Foundation | ₹1.33 Lakh (FY 2024) | •••• | •••• | -46.0% | •••• | Varanasi, Uttar Pradesh, India |
| Oeuvre Technologies and Consulting Private Limited | ₹1.32 Lakh (FY 2021) | •••• | •••• | -94.0% | •••• | Bhubaneswar, Odisha, India |
Peers are the five companies nearest above and the five nearest below Indur Life Sciences by revenue in the Healthcare industry (Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Indur Life Sciences Private Limited
Indur Life Sciences Private Limited is audited by ANOOHYA AND ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANOOHYA AND ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Indur Life Sciences Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Indur Life Sciences Private Limited
Open charges
₹11 Cr
Satisfied charges
₹4.8 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Aug 2024 | Karnataka Bank Ltd. | ₹11 Cr | Open |
| 20 May 2019 | State Bank of India | ₹4.8 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Indur Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Indur Life Sciences.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Indur Life Sciences Private Limited
Indur Life Sciences Private Limited has 12 board changes on record since 2011: 5 appointments and 7 cessations. The latest: Ajay Kumar Reddy Karnavathula was appointed as Additional Director on 23 Mar 2023.
AGM
Indur Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Indur Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 11.00 Cr with Charge ID 100972406 was registered on 14 Aug 2024.
Charges
A charge registered on 20 May 2019 via Charge ID 100274661 with State Bank Of India was fully satisfied on 28 May 2024.
Appointed
Ajay Kumar Reddy Karnavathula was appointed as Additional Director.
Appointed
Gouthami Gankidi was appointed as Additional Director.
Ceased
Janga Reddy Bakaram ceased to be Additional Director.
Ceased
Raghotham Reddy Enakonda ceased to be Additional Director.
Appointed
Raghotham Reddy Enakonda was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 4.80 Cr registered on 20 May 2019 with Charge ID 100274661 was modified on 19 Aug 2020.
Charges
A charge with State Bank Of India amounted to Rs. 4.80 Cr with Charge ID 100274661 was registered on 20 May 2019.
Ceased
Ram Reddy Nalla ceased to be Director.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Indur Life Sciences Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Indur Life Sciences Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Indur Life Sciences Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Indur Life Sciences Private Limited
Indur Life Sciences has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCI5625C1ZW | Telangana | Active | 01 Jul 2017 |
| 29AACCI5625C1ZR | Karnataka | Active | 24 Mar 2021 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Indur Life Sciences Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indur Life Sciences Private Limited
Indur Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 18 March 2011 (15+ years old) and is registered under CIN U45208TG2011PTC073379.
Indur Life Sciences reported revenue of ₹1.35 Lakh for FY 2024 (down 99% YoY).
Indur Life Sciences has 5 current directors:
- Muralidhar Rambathri - Managing Director
- Raghotham Reddy Enakonda - Director
- Hema Rambathri - Director
- Gouthami Gankidi - Additional Director
- Ajay Kumar Reddy Karnavathula - Additional Director
Indur Life Sciences reported a net loss of ₹3.06 Lakh (net margin -226.5%) and EBITDA of -₹1.34 Lakh (EBITDA margin -99.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Indur Life Sciences is -89% over three years and -54% over five years. In the latest year (FY 2024) revenue fell 99%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Indur Life Sciences is 36AACCI5625C1ZW, registered in Telangana. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 29AACCI5625C1ZR (Karnataka).
The CIN (Corporate Identification Number) of Indur Life Sciences is U45208TG2011PTC073379. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indur Life Sciences was incorporated on 18 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Indur Life Sciences by revenue are Sunlarge Technology Park Private Limited, Yashoda Healthcare Private Limited, Primecare Global Private Limited, Inovio Clinical Trials Private Limited, Vrmdb Services Private Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Services).
Ajay Kumar Reddy Karnavathula was appointed as Additional Director on 23 Mar 2023. Gouthami Gankidi was appointed as Additional Director on 17 Mar 2023. Janga Reddy Bakaram ceased to be Additional Director on 22 Nov 2021. Indur Life Sciences has 12 board changes on record in total.
Yes, Indur Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0005024).